Professor | Jian Luo | Asia Growth Partners

Name	Jian Luo
Contact Information	jluo@bio.ecnu.edu.cn
Language ability	Chinese, English
Province	Shanghai

Name

Jian Luo

Contact Information

jluo@bio.ecnu.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	East China Normal University
Faculty	Life Sciences
Academic Background & Achievements	PhD in Cell Biochemistry, Chinese Academy of Sciences National Outstanding Youth, Ministry of Education High-level Young Talent
Work Experience	2010 - Present: Reviewer for international journals such as Cancer Res, Mol Oncol, Curr Mol Med 2017 - Present: Vice Director, East China Normal University-Shanghai Changzheng Hospital Bone Tumor Joint Research Center
Awards	2017: First Prize, Basic Research in Orthopedics, Chinese Medical Association 2017: First Prize, Shanghai Science and Technology Progress Award

University/Lab Affiliation and Title

East China Normal University

Faculty

Life Sciences

Academic Background & Achievements

PhD in Cell Biochemistry, Chinese Academy of Sciences
National Outstanding Youth, Ministry of Education High-level Young Talent

Work Experience

2010 - Present: Reviewer for international journals such as Cancer Res, Mol Oncol, Curr Mol Med
2017 - Present: Vice Director, East China Normal University-Shanghai Changzheng Hospital Bone Tumor Joint Research Center

Awards

2017: First Prize, Basic Research in Orthopedics, Chinese Medical Association
2017: First Prize, Shanghai Science and Technology Progress Award

Areas of Focus	Stem cell clinical therapy development G protein-coupled receptor signaling pathways Drug development for osteoporosis, arthritis, intervertebral disc degeneration, and bone tumors
Publications	RSPO2/RANKL-LGR4 signaling regulates osteoclastic pre-metastatic niche formation and bone metastasis, Luo J et al., 2022 PGE2 Activates EP4 in Subchondral Bone Osteoclasts to Regulate Osteoarthritis, Luo J et al., 2022

Areas of Focus

Stem cell clinical therapy development
G protein-coupled receptor signaling pathways
Drug development for osteoporosis, arthritis, intervertebral disc degeneration, and bone tumors

Publications

RSPO2/RANKL-LGR4 signaling regulates osteoclastic pre-metastatic niche formation and bone metastasis, Luo J et al., 2022
PGE2 Activates EP4 in Subchondral Bone Osteoclasts to Regulate Osteoarthritis, Luo J et al., 2022

Stem Cells Clinical Therapy G Protein Receptor Signaling Drug Development Osteoporosis Arthritis Intervertebral Disc Bone Tumors Pharmacology

Xi Zhi Guo - Shanghai Jiao Tong University

Jian Luo - East China Normal University

Li Weida - Tongji University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us